Precision positioning systems specialist Physik Instrumente (PI) recently introduced a new series of miniaturized, piezo-motor-driven linear positioners at the 2013 LASER World of PHOTONICS conference – the world’s largest trade show for lasers and photonics related products – in Munich, Germany.
Cognex has announced that it has released two new products, the Advantage 100 vision system and the AE2 Advantage engine designed for integration into Original Equipment Manufacturer (OEM) devices and equipment. OEM equipment designers can now take full advantage of powerful Cognex vision and code reading technology
Murata has announced the Murata Power Solutions MEJ1 series of isolated 1 Watt DC-DC converters. Encapsulated in a 7 pin SIP package, the MEJ1 series offers basic and supplementary isolation to the internationally recognized UL60950 standard.
The new Secura laboratory balance developed by Sartorius for applications in regulated areas such as pharmaceutical labs fulfills particularly high reliability requirements. The balance monitors its ambient conditions automatically, thereby preventing handling errors.
There are an array of factors that impact the design of medical devices, from available components to healthcare trends. In this Roundtable presentation, participants spoke to the way in which healthcare trends are impacting material development and, as a result, how materials are then impacting medical device design.
Ventana Medical Systems, Inc. (Ventana), a member of the Roche Group, today announced that it has signed a worldwide agreement with healthcare imaging expert Barco to provide Barco's leading diagnostic and clinical review display systems for use with the VENTANA Virtuoso image and workflow management system, offering a best-in-class, turnkey image viewing solution.
The growth in sales of medical technologies is set to outperform prescription medicines over the coming five years. Data from Evaluate Medtech indicates that over the period 2011 to 2018, the overall global compound annual growth rate for the sector will be 4.4%, in contrast to just 2.5% for drug products.
A simple vinegar test slashed cervical cancer death rates by one-third in a remarkable study of 150,000 women in the slums of India, where the disease is the top cancer killer of women. Doctors reported the results Sunday at a cancer conference in Chicago.
Scientists have taken a vital step forward in understanding how cells from skin tissue can be reprogrammed to become stem cells. New research could pave the way to generate these stem cells efficiently to better understand and develop treatments for diseases such as multiple sclerosis, Parkinson's disease, and muscular degeneration.
Through innovations to a printing process, researchers have made major improvements to organic electronics – a technology in demand for lightweight, low-cost solar cells, flexible electronic displays and tiny sensors. The printing method is fast and works with a variety of organic materials to produce semiconductors of strikingly higher quality than what has so far been achieved with similar methods.
Using the sensitive ears of a parasitic fly for inspiration, a group of researchers has created a new type of microphone that achieves better acoustical performance than what is currently available in hearing aids. The scientists will present their results at the 21st International Congress on Acoustics, held June 2-7 in Montreal.
Solta Medical, Inc., the global market leader in aesthetic skin treatments, today announced Isolaz ® 2, the next generation acne therapy device. Isolaz 2 effectively targets the root causes of acne through a unique, clinically proven combination of vacuum extraction for deep pore purification, broadband light to destroy...
Vasomedical to Raise Awareness about EECP@ Therapy as an Effective Treatment for Heart Disease in Diabetic PatientsJune 3, 2013 8:30 am | by The Associated Press | News | Comments
The American Heart Association (AHA) Heart Disease and Stroke 2013 Statistical Update reported that 19.7 million Americans over the age of twenty have physician-diagnosed diabetes, and there are an additional eight million Americans with undiagnosed diabetes. The top causes of disability and...
Continuing to demonstrate its ongoing commitment to advancing interventional treatments of peripheral artery disease and the evidence to support their adoption, Medtronic, Inc. announced today that enough patients have been enrolled in its clinical studies of the IN.PACT Admiral drug-eluting balloon to support the company's U.S. regulatory approval submission of the novel angioplasty device.
The Food and Drug Administration Modernization Act of 1997 (FDAMA) added the "De Novo" classification option as an alternate pathway to classify certain new devices that had automatically been placed in Class III due to lack of a predicate. The De Novo process applies to low and moderate risk devices that have been classified as class III because they were found not substantially equivalent (NSE) to existing devices.